Recursion Pharmaceuticals (RXRX) Divestments (2025)
Recursion Pharmaceuticals (RXRX) posted Divestments of -$4.4 million for Q1 2025.
Recursion Pharmaceuticals (RXRX) Divestments (2025) Analysis & Trends
Recursion Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at -$4.4 million for Q1 2025.
- Quarterly Divestments changed N/A year-over-year to -$4.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$4.4 million (changed N/A YoY) and the FY2025 annual result came in at -$4.4 million, changed N/A from the prior year.
- Divestments was -$4.4 million for Q1 2025 at Recursion Pharmaceuticals.
- Across five years, Divestments topped out at -$4.4 million in Q1 2025 and bottomed at -$4.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.57 Bn | 912.05 Mn | -6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -4.44 Mn |